BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 7895622)

  • 1. [Optimized methods for measuring coagulation factors II, IV, VII and X in cats].
    Mischke R; Deniz A; Nolte I
    Dtsch Tierarztl Wochenschr; 1994 Nov; 101(11):430-3. PubMed ID: 7895622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methodological aspects for the determination of the coagulative activity of coagulation factors II, V, VII and X from dog plasma].
    Mischke R
    Zentralbl Veterinarmed A; 1994 Aug; 41(6):431-42. PubMed ID: 7863734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of coagulation factors II, V, VII and X in healthy dogs--dependence on age, sex and breed].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 1994 Sep; 107(9):289-94. PubMed ID: 7980377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of prothrombin time measurements in canine plasma.
    Mischke R; Nolte I
    Am J Vet Res; 1997 Mar; 58(3):236-41. PubMed ID: 9055967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of canine factor VII deficient substrate plasma.
    Gaston LW; Spivack AR
    J Lab Clin Med; 1968 Oct; 72(4):548-55. PubMed ID: 5677303
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison between British Comparative Thromboplastin (BCT) and a factor II-VII-X determination method (simplastin A) based on fresh plasma samples from dicoumarol-treated patients.
    Korsan-Bengtsen K; Johsen M; Pehrsson NG
    Thromb Haemost; 1977 Feb; 37(1):98-103. PubMed ID: 65801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
    Mischke R; Deniz A; Nolte I
    Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of coagulation factors (II-VII-X) and kaolin partial thromboplastin time by the LKB 8600 Reaction Rate Analyser.
    Hjorth B; Kjaersgaard E
    Scand J Clin Lab Invest; 1977 Feb; 37(1):15-20. PubMed ID: 616022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood coagulation changes in rats during development of epithelioma.
    Tomasiuk R; Gawlowska H; Sawicka B; Mielicki W; Wierzbicki R
    Neoplasma; 1989; 36(2):179-84. PubMed ID: 2716922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Applicability of activated partial thromboplastin time (APTT) as a screening test of milk to medium deficiencies of coagulation factors in cats].
    Deniz A; Mischke R; Nolte I
    Dtsch Tierarztl Wochenschr; 1995 May; 102(5):206-8. PubMed ID: 8593777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment.
    Bertina RM; Westhoek-Kuipers ME; Alderkamp GH
    Thromb Haemost; 1981 Jun; 45(3):237-41. PubMed ID: 7281102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory control of oral anticoagulants. Definition of therapeutic range in terms of different thromboplastin preparations.
    Loeliger EA; Meuwisse-Braun JB; Muis H; Buitendijk FJ; Veltkamp JJ; Hemker HC
    Thromb Diath Haemorrh; 1970 Jun; 23(3):569-84. PubMed ID: 5432194
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood coagulation factors during epidemic hepatitis in children].
    Seiler G; Gröpl H
    Arch Kinderheilkd; 1969 Jul; 179(2):164-71. PubMed ID: 5802842
    [No Abstract]   [Full Text] [Related]  

  • 14. Sensitivity of commercial prothrombin time reagents to detect coagulation factor deficiencies in equine plasma.
    Mischke R; Junker J; Deegen E
    Vet J; 2006 Jan; 171(1):114-9. PubMed ID: 16427588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prothrombin complex in liver diseases].
    Radujkov Z; Borota R; Lucić A; Mudrić V; Vuković V
    Med Pregl; 1969; 22(7):389-93. PubMed ID: 5201403
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral anticoagulant therapy and international normalized ratios in swine.
    McGlasson DL; Brickey DA; Doe RH
    Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of N-acetylcysteine on the accuracy of the prothrombin time assay of plasma coagulation factor II+VII+X activity in subjects infused with the drug. Influence of time and temperature.
    Thorsen S; Teisner A; Jensen SA; Philips M; Dalhoff K; Bendtsen F
    Scand J Clin Lab Invest; 2009; 69(6):643-50. PubMed ID: 19530032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of extrinsic coagulation factors].
    Fukutake K; Ogiso J; Matsubare Y
    Nihon Rinsho; 1979 Jun; Suppl():2221-31. PubMed ID: 491115
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of factors V,VII and X].
    Fukutake K; Matsubara Y; Tamura H; Mikami T
    Nihon Rinsho; 1976; 34 suppl():2425-32. PubMed ID: 792518
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of plasma fraction I-O, ACC 76, PAMBA and haemarctin on the blood coagulation system of premature newborn infants].
    Rogner G
    Z Kinderheilkd; 1967; 101(3):230-41. PubMed ID: 5626847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.